ABC7 KABC on MSN
UCI Health launches promising clinical trial using CAR T-cell therapy to treat lupus
A promising clinical trial underway at UCI Health is aimed at helping patients achieve long-term remission.
Amgen’s bad luck in lupus may finally be coming to an end. Daxdilimab, a monoclonal antibody acquired from Horizon ...
Feb 3 (Reuters) - AstraZeneca said on Tuesday that the U.S. health regulator had rejected its application for an ...
Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.
A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in ...
A key mystery behind one of the most common autoimmune diseases may finally have an answer. Researchers at Northwestern Medicine and Brigham and Women’s Hospital say they’ve discovered a root cause of ...
Feb 3 (Reuters) - AstraZeneca said on Tuesday the U.S. health regulator has rejected its application for a self-injectable ...
The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.
The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results